These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15963242)

  • 21. Zotepine in Huntington's disease.
    Bonelli RM; Niederwieser G; Lahousen T; Hofmann P
    Hum Psychopharmacol; 2003 Apr; 18(3):227-9. PubMed ID: 12672176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
    Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
    Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Switching from clozapine to zotepine in patients with schizophrenia: a 12-week prospective, randomized, rater blind, and parallel study.
    Lin CC; Chiu HJ; Chen JY; Liou YJ; Wang YC; Chen TT; Bai YM
    J Clin Psychopharmacol; 2013 Apr; 33(2):211-4. PubMed ID: 23422395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Zotepine versus perazine in patients with paranoid schizophrenia: a double-blind controlled trial of its effectiveness].
    Wetzel H; von Bardeleben U; Holsboer F; Benkert O
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():23-9. PubMed ID: 1683336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia.
    Cooper SJ; Tweed J; Raniwalla J; Butler A; Welch C
    Acta Psychiatr Scand; 2000 Mar; 101(3):218-25. PubMed ID: 10721870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zotepine for behavioural and psychological symptoms in dementia: an open-label study.
    Rainer MK; Krüger-Rainer C; Haushofer M; Mucke HA
    CNS Drugs; 2004; 18(15):1165. PubMed ID: 15581386
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparison between the effectiveness of fluphenazine decanoate and oxyprothepin decanoate in schizophrenia (double-blind crossover study)].
    Balon R; Kabesh Ia; Papezhova G
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):116-8. PubMed ID: 6121437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rifampin-zotepine interaction reduces effectiveness of antipsychotic drugs in a stable schizophrenia patient.
    Pai MS; Yang SN; Shiah IS
    Psychiatry Clin Neurosci; 2012 Oct; 66(6):538. PubMed ID: 23066778
    [No Abstract]   [Full Text] [Related]  

  • 29. [Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind study].
    Fleischhacker WW; Barnas C; Stuppäck CH; Sperner-Unterweger B; Miller C; Hinterhuber H
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():10-3. PubMed ID: 1683332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative clinical study of oxyprothepin and clothepin in psychoses.
    Svejkovská J; Kindernayová H; Zapletálik M
    Act Nerv Super (Praha); 1978 Dec; 20(4):270. PubMed ID: 32726
    [No Abstract]   [Full Text] [Related]  

  • 31. Hyperhidrosis under combination of zotepine and haloperidol alleviated by aripiprazole.
    Huang WL; Chang LR
    Psychiatry Clin Neurosci; 2012 Apr; 66(3):245. PubMed ID: 22443252
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effectiveness and tolerance of zotepine in a double-blind comparison with perazine in schizophrenic patients].
    Dieterle DM; Müller-Spahn F; Ackenheil M
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():18-22. PubMed ID: 1683334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of an open phase II study with zotepine--a new neuroleptic compound.
    Fleischhacker WW; Unterweger B; Barnas C; Stuppäck C; Hinterhuber H
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):64-6. PubMed ID: 2883686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hyperlipidemia--side-effect of the treatment with an atypical antipsychotic (zotepine)?].
    Wetterling T
    Psychiatr Prax; 2002 Nov; 29(8):438-40. PubMed ID: 12436365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Convulsive seizures in schizophrenic patients induced by zotepine administration.
    Hori M; Suzuki T; Sasaki M; Shiraishi H; Koizumi J
    Jpn J Psychiatry Neurol; 1992 Mar; 46(1):161-7. PubMed ID: 1353125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perathiepine in psychiatry: search for its indications.
    Vinar O; Ledererová E; Bastecký J
    Act Nerv Super (Praha); 1967 Nov; 9(4):429-30. PubMed ID: 4889079
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical effectiveness of zotepine in treatment of negative schizophrenic symptoms. Results of an open and a double-blind controlled trial].
    Müller-Spahn F; Dieterle D; Ackenheil M
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():30-5. PubMed ID: 1683337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement in QTc prolongation induced by zotepine following a switch to perospirone.
    Suzuki Y; Watanabe J; Sugai T; Fukui N; Ono S; Tsuneyama N; Saito M; Someya T
    Psychiatry Clin Neurosci; 2012 Apr; 66(3):244. PubMed ID: 22443250
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical and EEG studies of zotepine, a thiepine neuroleptic, on schizophrenic patients.
    Higashi Y; Momotani Y; Suzuki E; Kaku T
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):8-11. PubMed ID: 2883687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profiles of clinical efficacy and pharmacological action of zotepine.
    Yamawaki S
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):4-7. PubMed ID: 2883681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.